A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia

被引：6
|
作者：
Taylor, Mark [1 ]
Huang, Hannah Chu-Han [2 ]
机构：
[1] Univ Queensland, Inala Mental Hlth, 64 Wirraway Pde, Brisbane, Qld 4077, Australia
[2] South London & Maudsley Trust, London, England
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 10期
关键词：
INJECTIONS;
D O I：
10.1177/2045125317721874
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：231 / 233
页数：3
相关论文
共 50 条
  • [41] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Maju Mathews
    Huiling Pei
    Adam Savitz
    Isaac Nuamah
    David Hough
    Larry Alphs
    Srihari Gopal
    Clinical Drug Investigation, 2018, 38 : 695 - 702
  • [42] "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients
    Ferraro, Vincent
    Lafreniere, Simon
    Demers, Marie-France
    Roy, Marc-Andre
    Abdel-Baki, Amal
    PSYCHOPHARMACOLOGY, 2020, 237 (12) : 3795 - 3797
  • [43] “Real world” clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients
    Vincent Ferraro
    Simon Lafrenière
    Marie-France Demers
    Marc-André Roy
    Amal Abdel-Baki
    Psychopharmacology, 2020, 237 : 3795 - 3797
  • [44] Paliperidone Palmitate 3-Monthly Versus 1-Monthly Injectable in Patients With Schizophrenia With or Without Prior Exposure to Oral Risperidone or Paliperidone: A Post Hoc, Subgroup Analysis
    Mathews, Maju
    Pei, Huiling
    Savitz, Adam
    Nuamah, Isaac
    Hough, David
    Alphs, Larry
    Gopal, Srihari
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 695 - 702
  • [45] ECONOMIC ANALYSIS OF PALIPERIDONE LONG-ACTING ACTING INJECTABLE FOR CHRONIC SCHIZOPHRENIA IN PORTUGAL
    Maia-Lopes, S.
    Van Impe, K.
    Goswami, P.
    Einarson, T. R.
    VALUE IN HEALTH, 2015, 18 (07) : A410 - A410
  • [46] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Patel, R.
    Chesney, E.
    Taylor, M.
    Taylor, D.
    McGuire, P.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (10) : 1616 - 1623
  • [47] EFFICACY AND TOLERABILITY OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE IN THE TREATMENT OF DUAL PSYCHOSIS
    Vazquez Vazquez, J. M.
    Gonzalez-Rodriguez, A.
    Sanz Asin, P.
    Vicente Perellon, L.
    Lopez Garcia, F. J.
    Cruz Alonso, C.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [48] Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
    Desai, Mitesh
    Wooller, Annette
    Lignugaris, Arunas
    Gopal, Srihari
    PSYCHOLOGICAL MEDICINE, 2018, 48 (12) : 2098 - 2099
  • [49] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [50] Effects of Long-Acting Injectable Paliperidone Palmitate on Clinical and Functional Outcomes in Patients With Schizophrenia Based on Illness Duration
    Kim, Seoyoung
    Kim, SuYoun
    Koh, MinJung
    Choi, GumJee
    Kim, Jung-Jin
    Paik, In-Ho
    Kim, Seung-Hyun
    Choi, Yong-Sung
    Lee, Yohan
    Suh, Jaewon
    Takeuchi, Hiroyoshi
    Uchida, Hiroyuki
    Kim, Euitae
    JOURNAL OF CLINICAL PSYCHIATRY, 2021, 82 (01)
12345